The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 501–600 of 1,810
Elnageeb, M. E., Elfaki, I., Eleragi, A. M. S., Ahmed, E. M., Mir, R., Alzahrani, S. M., Bedaiwi, R. I., Alharbi, Z. M., Mir, R., Ajmal, M. R., et al. (2024) · Molecules · doi:10.3390/molecules29081904 · Cited by 13
Alharbi, K. K., Alsaikhan, A. S., Alshammary, A. F., Al-Hakeem, M. M., & Khan, I. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.08.102 · Cited by 12
“GDM affects 14% of pregnancies throughout the global women (Plows et al., 2018) and surprisingly in Saudi Arabia, the prevalence rate of GDM was documented to be around 39% (Alfadhli et al., 2015).”
BackgroundLi, T., Wang, W., Li, S., & Gong, C. (2023) · Journal of Oleo Science · doi:10.5650/jos.ess23066 · Cited by 12
Li, K., Jin, J., Liu, Z., Chen, C., Huang, L., & Sun, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2455789 · Cited by 16
Gölbaşı, H., Bayraktar, B., Gölbaşı, C., Ömeroğlu, İ., Adıyaman, D., Sever, B., & Ekin, A. (2022) · Journal of Perinatal Medicine · doi:10.1515/jpm-2022-0050 · Cited by 12
Gestational and pregestational diabetes in pregnant women with cystic fibrosis
Oxman, R., Roe, A. H., Ullal, J., & Putman, M. S. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100289 · Cited by 18
Beldie, L.-A., Dica, C.-C., Moța, M., Pirvu, B.-F., Burticală, M.-A., Mitrea, A., Clenciu, D., Efrem, I. C., Vladu, B. E., Timofticiuc, D. C. P., et al. (2024) · Nutrients · doi:10.3390/nu16234131 · Cited by 17
“…and Coustan criteria, 1.4% and 50% for the NDDG criteria, 2% and 24.5% using WHO criteria and 2% and 19% based on IADPSG criteria [6]. and 38% with the Carpenter and Coustan criteria, 1.4% and 50% for the NDDG criteria, 2% and 24.5% using WHO criteria and 2% and 19% based on IADPSG…”
InfluentialThe role of microRNAs in pregnancies complicated by maternal diabetes
Owen, M. D., Kennedy, M., Quilang, R., SCOTT, E. M., & Forbes, K. A. (2024) · Clinical Science · doi:10.1042/cs20230681 · Cited by 15
Aberrant NK cell profile in gestational diabetes mellitus with fetal growth restriction
Xiong, Y., Wang, Y., Wu, M., Chen, S., Lei, H., Mu, H., Yu, H., Hou, Y., Tang, K., Chen, X., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346231 · Cited by 17
Wang, J., Wu, Y., Yang, J., Ying, S., Luo, H., Zha, L., & Li, Q. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115634 · Cited by 11
Zheng, Z.-X., Feng, X., & Zhuang, L. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01417-3 · Cited by 16
“There is also evidence that adipose expandability, low-grade chronic in fl ammation, gluconeogenesis, oxidative stress, and placental factors contribute to the pathology of GDM [12, 13].”
Xilifu, N., Zhang, R., Dai, Y., Maimaiti, M., Li, Z., Yang, J., Zang, S., & Liu, J. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01278-8 · Cited by 13
Mayadunne, T., Saadati, S., Asmelash, D., Mason, T., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16418 · Cited by 17
“12,13 While a detailed discussion of the efficacy and role of metformin in these conditions is beyond the scope of this review, indications in T2DM, 14 PCOS, 15 and GDM 1 have recently been reviewed elsewhere.”
Zhou, X., Zhang, H., Jiang, Y., Wei, L., Chen, Y., Zhang, J., Gao, P., Zhu, S., Fang, C., Du, Y., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201611r · Cited by 14
Evaluation of thiol/disulfide homeostasis in patients with gestational diabetes mellitus
Cakina, S., Aydın, B., & Beyazıt, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1769062 · Cited by 11
Distribution of complete blood count constituents in gestational diabetes mellitus
Zhang, Y., Zhang, Y., Zhao, L., Shang, Y., He, D., & Chen, J. (2021) · Medicine · doi:10.1097/md.0000000000026301 · Cited by 15
“In total, 1878 gestational women met the criteria for inclusion in the study, which comprised 872 controls (normal pregnancies) and 1006 GDM. Eighteen patients were excluded from the study owing to a lack of outcome data.”
BackgroundInfluentialWang, X., Huang, J., Zheng, Y., Long, S., Lin, H., Zhang, N., Tian, M., Wu, X., An, R., Ma, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99836-2 · Cited by 15
Athanasiadou, K. I., Paschou, S. Α., Markozannes, G., Vasileiou, V., Kanouta, F., Mitropoulou, M., Antsaklis, P. G., Theodora, M., Ψαλτοπούλου, Θ., Daskalakis, G. J., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04329-1 · Cited by 13
“Fasting hyperglycemia indicates primarily hepatic insulin resistance (impaired insulin sensitivity), while post-load hyperglycemia indicates defective insulin secretion and insulin resistance at the skeletal muscle level [11, 12].”
Massalha, M., Iskander, R., Hassan, H., Spiegel, E., Erez, O., & Nachum, Z. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1527076 · Cited by 16
Zhang, J., & Bai, W. (2021) · Bioengineered · doi:10.1080/21655979.2021.2012906 · Cited by 12
“It is generally believed that the pathogenesis of GDM is complex, which may be the result of multiple factors such as inflammatory factors, insulin resistance (IR), pancreatic β-cell function defects, genetics and environment [6].”
BackgroundRetractedTang, M., Luo, M., Lu, W., Zhang, R., Liang, W., Gu, J., Yu, X., Zhang, X., & Hu, C. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00523-2 · Cited by 12
Multiple novel functions of circular RNAs in diabetes mellitus
Tehrani, S. S., Goodarzi, G., Panahi, G., Maniati, M., & Meshkani, R. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1933047 · Cited by 12
“GDM affects approximately 14% of pregnancies worldwide, equalling about 18 million cases annually (Plows et al. 2018).”
BackgroundSana, S.-R.-G.-L., Li, E.-Y., Deng, X., & Guo, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i33.10161 · Cited by 11
Increased fetal epicardial fat thickness: A reflecting finding for GDM and perinatal outcomes
İskender, C., Yücel, K. Y., Dereli, M. L., Sağlam, E., Çelen, Ş., Çağlar, T., & Üstün, Y. E. (2022) · Echocardiography · doi:10.1111/echo.15416 · Cited by 16
“Inflammatory factors leading to insulin resistance and beta cell dysfunction triggered by placental hormones play an important role in the etiopathogenesis of the disease, along with obesity, genetic and environmental factors [2-5].”
BackgroundFeyissa, T. R., Chojenta, C., Abate, K. H., Beyene, A. S., Khan, M. N., Bagade, T., & Harris, M. L. (2025) · Midwifery · doi:10.1016/j.midw.2025.104342 · Cited by 23
Placental neurotrophin levels in gestational diabetes mellitus
Jadhav, A. T., Khaire, A. A., Gundu, S., Wadhwani, N. S., Chandhiok, N., Gupte, S., & Joshi, S. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10107 · Cited by 10
Effects of gestational diabetes mellitus on offspring: A literature review
Li, T., Ma, X., & Ma, L. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70185 · Cited by 16
“10,62 The HAPO follow-up study (FUS) in the USA included 4160 children aged 10–14 years and their mothers to examine GDM and its bad effects.”
Maternal glucose in pregnancy is associated with child's adiposity and leptin at 5 years of age
Blais, K., Arguin, M., Allard, C., Doyon, M., Dolinsky, V. W., Bouchard, L., Hivert, M., & Perron, P. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12788 · Cited by 10
“Leptin is a hormone secreted by the adipocytes, is a marker of overall adiposity and plays an important part in appetite regulation by transmitting the satiety signal to the hypothalamus.(2,4)”
BackgroundLee, S., Yu, J. S., Han, K., Lee, S., You, S. Y., Kim, H., Cho, J., Yoon, K., & Kim, M. K. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1609 · Cited by 11
“Mothers with GDM are more likely to develop postpartum type 2 diabetes mellitus (DM), high blood pressure, preeclampsia, cesarean section, and cardiovascular disease [2,4].”
Vorobjova, T., Tagoma, A., Talja, I., Janson, H., Kirss, A., & Uibo, R. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1089434 · Cited by 15
Gestational Diabetes Mellitus Alters Cytokine Profiles and Macrophage Polarization in Human Placenta
Barbosa, M. R., de Marchi, G. F., Silva, K. M. R., França, D. C. H., da Silva, M. A. B., Barbosa, J. R., Melo, L. V. L., França, E. L., & Honório‐França, A. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210867 · Cited by 21
“Although GDM is associated with systemic elevations in IL-6 [31], local downregulation of these cytokines at the placental interface may represent a compensatory mechanism to prevent excessive inflammation and protect fetal tissues [32].”
Rahmi, R. M., de Oliveira, P., Selistre, L. D. S., Rezende, P. C., Pezzella, G. N., dos Santos, P. A., Vergani, D. D. O. P., Madi, S. R. C., & Madi, J. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253047 · Cited by 13
“Current evidences support the strong association between obesity and gestational diabetes mellitus (GDM) [4, 5].”
Risk of type 2 diabetes after diagnosed gestational diabetes is enhanced by exposure to PM2.5
Pan, S., Huang, C., Chen, B., Chin, W., & Guo, Y. L. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad071 · Cited by 13
Lü, L., He, L., Hu, J., & Li, J. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05449-0 · Cited by 17
“AMA has been identified as a risk factor for GDM [6].”
BackgroundRon, I., Mdah, R., Zemet, R., Ulman, R. Y., RATHAUS, M., Brandt, B., Mazaki‐Tovi, S., Hemi, R., Barhod, E., & Tirosh, A. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15214 · Cited by 11
Hager, M., Ott, J., Castillo, D. M., Springer, S., Seemann, R., & Pils, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051523 · Cited by 11
“increase in early and a decrease in later pregnancy [5].”
BackgroundZhu, J. J., Jiang, S., Jiang, X., Luo, K., Huang, X., & Hua, F. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1909-1922 · Cited by 12
“Although the exact mechanisms of GDM are still unclarified, insulin resistance was considered as the main mechanism elaborated in the pathogenesis of GDM [31].”
Maternal and Child Health, Non-Communicable Diseases and Metabolites
Cerf, M. E. (2023) · Metabolites · doi:10.3390/metabo13060756 · Cited by 15
Wang, Y., Ren, Q., Yuan, H., Wang, Y., Liu, Y., Wei, Y., Sun, R., Yang, H., Tian, P., Yang, J., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1486848 · Cited by 14
“Age and obesity are also strongly associated with GDM (44 – 46).”
Li, X., Zhang, L., He, Y., Zhang, D., & Zhang, S. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10377 · Cited by 14
“…for GDM, multiple mechanisms may be involved in the pathogenesis of GDM besides dysregulation of intestinal microbiota, suchasisletbeta-celldysfunction,insulinresistance,neurohor-monal dysregulation, oxidative stress, and inflammation [48], and probiotics supplementation may become less effective.”
BackgroundGestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Quaresima, P., Myers, S. H., Pintaudi, B., D’Anna, R., Morelli, M., & Unfer, V. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501110 · Cited by 21
Lyu, Y., Wang, G., Sun, Z., Cui, X., Xiu, Q., & Wu, L. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00227-x · Cited by 12
“Since oxidative stress is a known cause of cellular damage by interfering with the state of proteins, lipids, and DNA, and has been implicated in the pathogenesis of metabolic and hypertensive disorders of pregnancy, including GDM [10, 11], we hypothesized that insufficient antioxidant defenses in early pregnancy may…”
BackgroundFrom Molecular Insights to Clinical Management of Gestational Diabetes Mellitus—A Narrative Review
Assani, M.-Z., Boldeanu, L., Manolea, M. M., Boldeanu, M. V., Siloşi, I., Assani, A.-D., Văduva, C.-C., & Dijmărescu, A. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178719 · Cited by 14
“Pregnancy-induced insulin resistance is driven by placental hormones (human placental lactogen (hPL), placental growth hormone, estrogen, progesterone, cortisol) and inflammatory cytokines (tumor necrosis factor α (TNF α ), interleukin 6 (IL-6), interleukin 1 β (IL-1 β )) [10,20].”
Alduayji, M. M., & Selim, M. (2023) · Cureus · doi:10.7759/cureus.44200 · Cited by 25
“Hormonal changes during pregnancy that affect insulin production and utilization are the major cause of GDM [3].”
Bridge-Comer, P. E., Vickers, M. H., Morton-Jones, J., Spada, A., Rong, J., & Reynolds, C. M. (2022) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174422000022 · Cited by 11
Self-citationDu, X., Shi, H., Liu, H., Zhou, L., Xie, A., & Guo, J. (2022) · ONCOLOGIE · doi:10.32604/oncologie.2022.026248 · Cited by 10
Looking at the Future Through the Mother’s Womb: Gestational Diabetes and Offspring Fertility
Sinha, N., Walker, G. L., & Sen, A. (2021) · Endocrinology · doi:10.1210/endocr/bqab209 · Cited by 11
Yang, N., Zhang, W., Cheng, J., Ge, J., Zhang, X., Li, M., Wang, M., Zhang, T., He, J., & Zhu, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196935 · Cited by 19
“Current studies suggested other potential factors related to IR in pregnant women, including levels of steroid hormones, placental hormones, and inflammatory mediators, which function as antagonists to insulin (16).”
BackgroundMontazeri‐Najafabady, N., Dabbaghmanesh, M. H., Jahromi, B. N., Chatrabnous, N., & Chatrsimin, F. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1757062 · Cited by 12
“Overweight/obesity, westernized diet and micronutrient deficiencies, advanced maternal age, and a family history of insulin resistance and/or diabetes are considered as GDM risk factors [5].”
BackgroundThe role of complement factor H in gestational diabetes mellitus and pregnancy
Li, J., Shen, Y., Tian, H., Xie, S., Ji, Y., Li, Z., Lu, J., Lu, H., Liu, B., & Liu, F. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04031-w · Cited by 10
Schenk, S., Ravussin, Y., Lacroix, A., Quansah, D. Y., & Puder, J. J. (2024) · Nutrients · doi:10.3390/nu16040560 · Cited by 10
“In the perinatal period, pre-pregnancy overweight (25.0–29.9 kg/m 2 ) and obesity ( ≥ 30 kg/m 2 ) are associated with adverse outcomes for the mother and the offspring [5], including, for the mother, an increased risk of gestational diabetes mellitus (GDM) [6].”
BackgroundInfluentialTangjittipokin, W., Thanatummatis, B., Wardati, F., Narkdontri, T., Teerawattanapong, N., & Boriboonhirunsarn, D. (2023) · Gene · doi:10.1016/j.gene.2023.147228 · Cited by 11
Risk factors for retained placenta in a first pregnancy—A clinical trial
Cohen, G., Kovo, M., Biron‐Shental, T., Markovitch, O., Daykan, Y., & Schreiber, H. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14800 · Cited by 14
Babović, I. R., Dotlić, J., Sparić, R., Jovandarić, M. Z., Andjić, M., Marjanović-Cvjetičanin, M., Akšam, S. S., Bila, J. S., Tulić, L., Kocijancic, D., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010323 · Cited by 11
“The placenta is also particularly sensitive to maternal hyperglycemia throughout pregnancy, and it directly contributes to fetal macrosomia [31,32].”
BackgroundGestational Diabetes Mellitus in the Setting of Polycystic Ovarian Syndrome: A Systematic Review
Slouha, E., Alvarez, V. C., Gates, K. M., Ankrah, N. M. N., Clunes, L. A., & Kollias, T. F. (2023) · Cureus · doi:10.7759/cureus.50725 · Cited by 24
GLP‐1 rescued gestational diabetes mellitus‐induced suppression of fetal thalamus development
You, L., Deng, Y., Li, D., Lin, Y., & Wang, Y. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23258 · Cited by 11
Ortega-Montiel, J., Martínez‐Juárez, L. A., Montoya, A., Morales‐Juárez, L., Gallardo‐Rincón, H., Galicia-Hernández, V., García-Cerde, R., Ríos-Blancas, M. J., Álvarez-Hernández, D.-A., Lomelín‐Gascón, J., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s450939 · Cited by 12
“29,34 Our results indicate that adverse maternal outcomes can also impact newborns.”
BackgroundShen, Y., Zheng, Y., Su, Y., Jiang, S., Ma, X., Hu, J., Li, C., Huang, Y., Teng, Y., Bao, Y., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002337 · Cited by 12
“Previous studies have shown that both b cell function and insulin sensitivity may be involved in the pathogenesis of GDM.([8]) For a healthy pregnancy, insulin”
BackgroundInfluentialYang, L., Zhou, Y., Jiang, M., Wen, W., Guo, Y., Pakhale, S. S., & Wen, S. W. (2024) · Public health reviews · doi:10.3389/phrs.2024.1605579 · Cited by 10
“Pregnancy could also trigger some diseases such as asthma attack [59].”
BackgroundYavorov-Dayliev, D., Milagro, F. I., Ayo, J., Oneca, M., Goyache, I., Lópeź‐Yoldi, M., FitzGerald, J. A., Crispie, F., Cotter, P. D., & Aranaz, P. (2025) · Life Sciences · doi:10.1016/j.lfs.2024.123359 · Cited by 10
Yao, X., Huang, S., Li, Y., Ge, Y., Zhang, Z., Ning, J., & Yang, X. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109131 · Cited by 12
Byrne, J., Ranaei‐Zamani, N., Hutchinson, J. C., & Hillman, S. L. (2025) · Placenta · doi:10.1016/j.placenta.2025.02.008 · Cited by 17
Comparative Evaluation of Adipokine Metrics for the Diagnosis of Gestational Diabetes Mellitus
Kamiński, M., Mierzyński, R., Poniedziałek‐Czajkowska, E., Sadowska, A., Sotowski, M., & Leszczyńska‐Gorzelak, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010175 · Cited by 12
“According to global data, GDM affects about 14% of pregnant women worldwide [1,2].”
BackgroundCosma, V., Imbernon, J., Zagdoun, L., Boulot, P., Renard, É., Brunet, C., Marès, P., Rodier, M., Kabani, S., Dematteï, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89679-2 · Cited by 11
Bartáková, V., Barátová, B., Pácal, L., Ťápalová, V., Šebestová, S., Janků, P., & Kaňková, K. (2021) · Life · doi:10.3390/life11060464 · Cited by 10
“Higher body mass index (BMI) before pregnancy, older maternal age, smoking and positive family history of diabetes (DM) are all considered as risk factors for developing GDM [9].”
BackgroundZhang, Q., Dong, Y., & Fan, J. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.12.007 · Cited by 11
Zhang, H., Dai, J., Zhang, W., Sun, X., Sun, Y., Wang, L., Li, H., & Zhang, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216832 · Cited by 10
Meakin, A., Gough, M., Saif, Z., & Clifton, V. (2022) · Placenta · doi:10.1016/j.placenta.2022.02.010 · Cited by 8
COBLL1 and IRS1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes
Ustianowski, P., Malinowski, D., Czerewaty, M., Safranow, K., Tarnowski, M., Dziedziejko, V., & Pawlik, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081933 · Cited by 13
“Studies suggest that the pathogenesis of GDM is similar to that of type 2 diabetes mellitus (T2DM) [3,5].”
BackgroundActivin A and pathologies of pregnancy: a review
Barber, C., Yo, J. H., Rahman, R. A., Wallace, E. M., Palmer, K. R., & Marshall, S. A. (2023) · Placenta · doi:10.1016/j.placenta.2023.03.008 · Cited by 10
Early prediction of postpartum dyslipidemia in gestational diabetes using machine learning models
Jiang, Z., Chen, X., Lai, Y., Liu, J., Ye, X., Chen, P., & Zhang, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-92299-9 · Cited by 9
Rodrigo, N., Randall, D., Al-Hial, F. A., Pak, K. L. M., Kim, A. J., & Glastras, S. J. (2023) · Nutrients · doi:10.3390/nu15051226 · Cited by 13
“GDM arises from a multifaceted process of β-cell dysfunction, oxidative stress and chronic insulin resistance, which is compounded by placental metabolic hormones and cytokines, thereby transforming the physiological insulin resistance of pregnancy into the pathophysiological condition of GDM [12].”
BackgroundAkash, M. S. H., Noureen, S., Rehman, K., Nadeem, A., & Khan, M. A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1242939 · Cited by 10
Salahi, P., Alirezaei, M., Kheradmand, A., & Rocky, A. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09922-3 · Cited by 10
Wang, S., Dongyang, W., Sun, X., Li, Y., Li, D., & Chen, B. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1810705 · Cited by 12
Mechanisms of Insulin Resistance during Pregnancy
Leoni, M., Padilla, N., Fabbri, A., Della‐Morte, D., Ricordi, C., & Infante, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107907 · Cited by 12
Arain, H., Patel, T., Mureanu, N., Efthymiou, A., Lombardi, G., Tree, T. I. M., Nicolaides, K. H., & Shangaris, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226617 · Cited by 10
“Recent evidence also suggests an association with a maternal state of chronic low-grade in fl ammation where there is immune dysregulation through enhanced T-cell activation and increased circulating levels of proin fl ammatory cytokines (7, 8).”
BackgroundNaydenov, D. D., Vashukova, E. S., Barbitoff, Y. A., Nasykhova, Y. A., & Glotov, A. S. (2023) · Genes · doi:10.3390/genes14030756 · Cited by 10
“An additional problem is an inconsistency in the screening and diagnosis of GDM in different countries, which makes it difficult to estimate this condition [90].”
BackgroundNutrition-Education-Based Interventions in Gestational Diabetes: A Scoping Review of Clinical Trials
Helm, M. M., Izuora, K. E., & Basu, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912926 · Cited by 18
First-Trimester Maternal Serum Adiponectin/Leptin Ratio in Pre-Eclampsia and Fetal Growth
de Knegt, V. E., Hedley, P. L., Eltvedt, A. K., Placing, S., Wøjdemann, K. R., Shalmi, A. C., Rode, L., Kanters, J. K., Sundberg, K., Tabor, A., et al. (2023) · Life · doi:10.3390/life13010130 · Cited by 10
“Pre-pregnancy IR is associated with the development of gestational diabetes mellitus (GDM) [14], with an ensuing risk of fetal over-nutrition and macrosomia [15–17], as well as PE [18].”
BackgroundInfluentialChaves, C., Cunha, F. M., Martinho, M., Garrido, S., Silva-Vieira, M., Estevinho, C., Melo, A., Figueiredo, O., Morgado, A., Nogueira, C., et al. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06107-6 · Cited by 10
Zhang, C., Wang, L., Sun, W., Chen, L., Zhang, C., Hong, L., Yu, J., Fan, J., Ruan, H., Zheng, T., et al. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04039-2 · Cited by 10
Early-pregnancy maternal heart rate is related to gestational diabetes mellitus (GDM)
Qiu, J., Chen, L., Wang, X., & Zhu, W. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.11.007 · Cited by 10
Jia, X., Bai, L., Ma, N., & Lu, Q. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13889 · Cited by 13
Alternative cleavage and polyadenylation: key regulatory mechanisms in health and disease
Zhang, Y., Huang, Z., Lu, W., & Liu, Z. (2025) · RNA Biology · doi:10.1080/15476286.2025.2529033 · Cited by 20
“GDM is characterized by varying degrees of glucose intolerance that manifests for the first-time during pregnancy [227].”
Li, L., Li, L., Shao, Y., Du, R., Li, L., Shi, X., & Bai, Y. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00669-8 · Cited by 12
Ding, L., Shen, Y., Wang, A., Lu, C., Gu, X., & Jiang, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.966296 · Cited by 10
“Gestational diabetes mellitus (GDM) is a comprehensive form of pregnancy-specific glucose intolerance or hyperglycemia that manifests certain degree of glucose intolerance (Plows et al., 2018).”
BackgroundTunç, Ş., Oğlak, S. C., Ölmez, F., & Özköse, Z. G. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.06.722 · Cited by 10
Continuous Subcutaneous Insulin Infusions: Closing the Loop
Díaz-Balzac, C. A., Pillinger, D., & Wittlin, S. D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac746 · Cited by 11
Biochemical Markers in the Prediction of Pregnancy Outcome in Gestational Diabetes Mellitus
Mandić, V., Dobrijević, Z., Robajac, D., Miljuš, G., Šunderić, M., Penezić, A., Nedić, O., Ardalić, D., Miković, Ž., Radojičić, O., et al. (2024) · Medicina · doi:10.3390/medicina60081250 · Cited by 16
“It has been proven that different biomolecules are altered in GDM pregnancies, with a relatively high potential to enable early prediction of GDM [7].”
BackgroundOğlak, S. C., Aşir, F., Yılmaz, E. Z., Bolluk, G., Korak, T., & Ağaçayak, E. (2024) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2451-2223 · Cited by 14
Impact of Maternal Overweight and Obesity on Adipokines During Pregnancy and Lactation
Froń, A., Tomecka, P., & Orczyk‐Pawiłowicz, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199757 · Cited by 17
“GDM is associated with macrosomia, neonatal hypoglycemia, and an increased long-term risk of type 2 diabetes in both the mother and her child [5,71].”
Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)
Alshammari, M. A., Alshehri, A. O., Alqahtani, F., Khan, M. R., Bakhrebah, M. A., Alasmari, F. F., Alshammari, T. K., & AlSharari, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147768 · Cited by 12
“The real-time PCR analyses were performed using the CFX96 Real-Time Detection System (Bio-Rad) [81].”
MethodLiu, X., Wang, N., & Gao, Z. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13712 · Cited by 12
“Additionally, downregulation of SHBG was observed in the placenta of women with GDM. SHBG, more than a glycated homodimeric plasma transporter of sex steroids, has emerged as a genetic factor that participates in the pathophysiology of insulin resistance and T2DM.28 Sun and colleagues have already found that SHBG was…”
BackgroundInfluentialKanney, N., Patki, A., Chandler-Laney, P., Garvey, W. T., & Hidalgo, B. A. (2022) · Metabolites · doi:10.3390/metabo12121226 · Cited by 10
“Pregnant individuals with gestational diabetes mellitus (GDM) exhibit elevated plasma glucose levels and, in some instances, a greater risk for poor pregnancy outcomes [1].”
BackgroundLu, J., Wang, D., Ma, B., Gai, X., Kang, X., Wang, J., & Xiong, K. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02859-2 · Cited by 11
“Both GDM and T2DM are mainly due to cell dysfunction in a background of insulin resistance [57].”
BackgroundDamiri, B., Abumohsen, H., Belkebir, S., Hamdan, M., Saudi, L., Hindi, H., Abdaldaem, R., Bustami, B., Almusleh, A., & Yasin, O. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301145 · Cited by 11
The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus
Zhou, J., Zhe, R., Guo, X., Chen, Y., Zou, Y., Zhou, L., & Wang, Z. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s251491 · Cited by 10
Heath, H., DeGreef, K., Rosario, R., Smith, M., Mitchell, I., Pilolla, K. D., Phelan, S., Brito, A., & Frano, M. R. L. (2022) · Nutrition · doi:10.1016/j.nut.2022.111898 · Cited by 11
Decoding the Gut Microbiota–Gestational Diabetes Link: Insights from the Last Seven Years
Balleza-Alejandri, L. R., Peña-Durán, E., Beltrán-Ramírez, A., Reynoso-Roa, A. S., Sánchez-Abundis, L. D., García-Galindo, J. J., & Suárez-Rico, D. O. (2024) · Microorganisms · doi:10.3390/microorganisms12061070 · Cited by 13
“(GLUT4), through reduced tyrosine phosphorylation and increased threonine/serine in the insulin receptor [14].”
Background
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.